Welcome to the February 2014 issue of Pharmaceutical Technology Sourcing and Management, an information resource for contract manufacturing, ingredients sourcing, and the supply chain from the editors of Pharmaceutical Technology and Pharmaceutical Technology Europe. In this issue, see why there could be a shortage of CMO services for biologics, how R&D changes are impacting the contract services market, and read the latest business and corporate social responsibility developments from bio/pharmaceutical companies.

Manufacturing Trends
Will CMOs Provide Sufficient Capacity for Growing Biologics Demand?
With numerous biologics set to come off patent soon and the percentage of new therapeutics based on biomolecules growing, demand for contract manufacturing in the biopharma space is heating up.
More ...

The State of Drug Manufacturing in India
The State of Drug Manufacturing in India
Some recent high-profile cases of quality issues at Indian manufacturers have given reason to examine manufacturers more closely.
More ...

Outsourcing
Evolving R&D Model Pressures Contract Services Market
The R&D model is in transition and creating new demands on contract services providers.
More ...

Supply Chain
BASF Receives EXCiPACT Certification
BASF receives EXCiPACT Certification for the group of polyvinylpyrrolidone polymers, produced in Germany.
More ...

Supply Chain
VWR International Locations Join Avantor Performance Materials Distributor Program
Avantor Performance Materials adds VWR International locations to its certified excipient distributor program.
More ...

Corporate Social Responsibility
AstraZeneca, BMS Provide Grant for Diabetes Research Initiative
AstraZeneca and Bristol-Myers Squibb Diabetes Alliance provides a $5 million grant to the American Diabetes Association.
More ...

Corporate Social Responsibility
Catalent Applied Drug Delivery Institute Partners with AAPS on 3rd Annual Global Academic Competition
Competition seeks to encourage academic research and accelerate drug delivery applications.
More ...